86 related articles for article (PubMed ID: 25231075)
1. The evaluation of involvement of angiotensin II, its receptors, and androgen receptor in endometrial cancer.
Matysiak ZE; Ochędalski T; Piastowska-Ciesielska AW
Gynecol Endocrinol; 2015 Jan; 31(1):1-6. PubMed ID: 25231075
[TBL] [Abstract][Full Text] [Related]
2. Silencing of angiotensin receptor 1 interferes with angiotensin II oncogenic activity in endometrial cancer.
Matysiak-Burzyńska ZE; Nowakowska M; Domińska K; Kowalska K; Płuciennik E; Piastowska-Ciesielska AW
J Cell Biochem; 2018 Nov; 119(11):9110-9121. PubMed ID: 30105775
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor subtypes AT1 and AT2 are down-regulated by angiotensin II through AT1 receptor by different mechanisms.
Ouali R; Berthelon MC; Bégeot M; Saez JM
Endocrinology; 1997 Feb; 138(2):725-33. PubMed ID: 9003008
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II and the adrenal.
Giacchetti G; Opocher G; Sarzani R; Rappelli A; Mantero F
Clin Exp Pharmacol Physiol Suppl; 1996; 3():S119-24. PubMed ID: 8993850
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptors.
Ardaillou R
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S30-9. PubMed ID: 9892138
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the expression of angiotensin II type 1 receptor and VEGF in endometrial adenocarcinoma with different clinicopathological characteristics.
Piastowska-Ciesielska AW; Płuciennik E; Wójcik-Krowiranda K; Bieńkiewicz A; Bednarek A; Ochędalski T
Tumour Biol; 2012 Jun; 33(3):767-74. PubMed ID: 22170435
[TBL] [Abstract][Full Text] [Related]
7. Integration of androgen hormones in endometrial cancer biology.
Gjorgoska M; Rizner TL
Trends Endocrinol Metab; 2022 Sep; 33(9):639-651. PubMed ID: 35879182
[TBL] [Abstract][Full Text] [Related]
8. Correlation between VEGFR-2 receptor kinase domain-containing receptor (KDR) mRNA and angiotensin II receptor type 1 (AT1-R) mRNA in endometrial cancer.
Piastowska-Ciesielska AW; Płuciennik E; Wójcik-Krowiranda K; Bieńkiewicz A; Nowakowska M; Pospiech K; Bednarek AK; Domińska K; Ochędalski T
Cytokine; 2013 Feb; 61(2):639-44. PubMed ID: 23273598
[TBL] [Abstract][Full Text] [Related]
9. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
10. [The change of angiotensin II production and its receptor expression during wound healing: possible role of angiotensin II in wound healing].
Wu HJ; Liu HW; Cheng B; Gu YF; Xie B; Xiao LL; Shao JL; Lu JQ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Mar; 27(2):124-8. PubMed ID: 21774352
[TBL] [Abstract][Full Text] [Related]
11. Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.
Ikeda Y; Aihara K; Yoshida S; Sato T; Yagi S; Iwase T; Sumitomo Y; Ise T; Ishikawa K; Azuma H; Akaike M; Kato S; Matsumoto T
Endocrinology; 2009 Jun; 150(6):2857-64. PubMed ID: 19196803
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
Lee EY; Shim MS; Kim MJ; Hong SY; Shin YG; Chung CH
Exp Mol Med; 2004 Feb; 36(1):65-70. PubMed ID: 15031673
[TBL] [Abstract][Full Text] [Related]
13. Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II.
Laporte SA; Boucard AA; Servant G; Guillemette G; Leduc R; Escher E
Mol Endocrinol; 1999 Apr; 13(4):578-86. PubMed ID: 10194764
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptors: cloning and regulation.
Inagami T; Iwai N; Sasaki K; Guo DF; Furuta H; Yamano Y; Bardhan S; Chaki S; Makito N; Badr K
Arzneimittelforschung; 1993 Feb; 43(2A):226-8. PubMed ID: 8498969
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.
Choi CH; Park YA; Choi JJ; Song T; Song SY; Lee YY; Lee JW; Kim TJ; Kim BG; Bae DS
Gynecol Oncol; 2012 Jul; 126(1):124-31. PubMed ID: 22525818
[TBL] [Abstract][Full Text] [Related]
17. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
Dai JL; Burnstein KL
Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium.
Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T
Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305
[TBL] [Abstract][Full Text] [Related]
19. GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients.
Sasaki M; Karube A; Karube Y; Watari M; Sakuragi N; Fujimoto S; Dahiya R
Biochem Biophys Res Commun; 2005 Apr; 329(1):100-4. PubMed ID: 15721279
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of angiotensin II receptor internalization.
Hunyady L
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S47-56. PubMed ID: 9892140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
